usps-logo.jpg?1721728722
Ultrafast Ultrasonic Synthesis
Catalog peptides: immediate delivery
ISO 9001/2015 certified
1000 peptides & peptide pools
30 years of experience in peptide synthesis

HUMAN PRAME/OIP4 Peptide Pool

Pool of 125 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) (UniProt ID: P78395) of Homo sapiens (Human).

One unit allows the stimulation of 2,5 x 108 cells.

Gene:PRAME
Delivery:overnight
Counter Ion:TFA
Protein:Melanoma antigen preferentially expressed in tumors
UniProt Id:P78395
Species:Homo sapiens
Application :T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication :Cancer, Melanoma
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >

€217.35*

Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Product number: LB01686

Similar Items

PRAME 100-108 (HLA-A*02:01)
Single peptide (VLDGLDVLL) for stimulation of human Prame (100-108)-specific CD8+T cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele.

From €60.40*
PRAME 300–309 (HLA-A*02:01)
ALYVDSLFFL is a linear peptidic epitope (epitope ID225231) studied as part of Melanoma antigen preferentially expressed in tumors from Homo sapiens (human), tested in T cell assays. Antigen Peptide PRAME 300–309 (HLA-A*02:01) ALYVDSLFFL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

From €60.40*
HUMAN PRAME/OIP4 Peptide Pool
Pool of 125 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) (UniProt ID: P78395) of Homo sapiens (Human). One unit allows the stimulation of 2,5 x 108 cells.

€217.35*